Study to Evaluate the Safety and Efficacy of MEM 3454 as Adjunctive Treatment in Combination With a Preexisting Antipsychotic in Patients With Cognitive Impairment Associated With Schizophrenia
Clinical trial NCT00604760 · UNKNOWN
Trial details
- NCT number
- NCT00604760
- Sponsor
- Memory Pharmaceuticals
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-12-01
- Primary completion
- 2009-02-01
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.